Andrew Stagg

Dr. Andrew Stagg is a Senior Lecturer in Immunology at the Centre for Immunobiology, Blizard Institute, Queen Mary University of London. His research explores immune regulation in the human intestine, focusing on dendritic cells and their role in inflammatory bowel disease (IBD). He leads translational research groups and collaborates across clinical and academic institutions.

• Education: BSc (Hons) from University of Birmingham, PhD from MRC National Institute for Medical Research.

Research Interests: The Stagg Lab investigates mechanisms of intestinal immune homeostasis and how dysregulation leads to IBD. Key areas include dendritic cell biology, mucosal immunology, commensal microbiota interactions, and translational approaches to improve IBD therapies.

Article Trends: Recent publications emphasize dietary interventions (e.g., low FODMAP diets), T-cell signaling pathways (e.g., STAT1), and immunomodulatory therapies (e.g., azathioprine). They span microbiome analysis, inflammatory phenotypes, and retinoic acid's role in Crohn's disease.

Scientific Recognition: Awards include Fellowship of the Higher Education Academy (FHEA), acknowledging his educational contributions.

• Teaching Roles: Advanced Immunology (BSc), MBBS, MSc Clinical Microbiology, MSc Gastroenterology, MSc Physician Associate Studies.
• PhD Supervision: Mentoring students like Hannah Gordon and Beverley Rodger in intestinal immunology.